Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01987700 · ClinicalTrials.gov registry record · Phase 4
Multi-Center Study To Examine The Use Of Flex HD® And Strattice In The Repair Of Large Abdominal Wall Hernias
A Phase 4 study, sponsored by Musculoskeletal Transplant Foundation.
- Completed
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
NCT01987700 is a Phase 4 study that has completed, run by Musculoskeletal Transplant Foundation. The registered enrollment target is 120 participants.
The verdict
NCT01987700, a Phase 4 study, has completed, sponsored by Musculoskeletal Transplant Foundation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
Study Summary
The primary objective of this study is to examine and compare the outcomes associated with the use of Flex HD®, a human acellular dermal matrix (HADM), and Strattice™, a porcine acellular dermal matrix, (PADM) when used as a reinforcing material in the repair of large complicated abdominal wall hernias.
Interventions
- DEVICE FLEX-HD
- DEVICE Strattice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2013-07 |
| Est. Completion | 2018-08-25 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01987700
The ClinicalTrials.gov registry entry for NCT01987700 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Musculoskeletal Transplant Foundation, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FLEX-HD is the first listed.
NCT01987700 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01987700 about?
NCT01987700 is a clinical study titled "Multi-Center Study To Examine The Use Of Flex HD® And Strattice In The Repair Of Large Abdominal Wall Hernias". The primary objective of this study is to examine and compare the outcomes associated with the use of Flex HD®, a human acellular dermal matrix (HADM), and Strattice™, a porcine acellular dermal matrix, (PADM) when used as a reinforcing material in the repair of large complicated abdominal wall hern...
What is the current status of trial NCT01987700?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2013-07. Estimated completion is 2018-08-25.
What interventions are being tested in trial NCT01987700?
The interventions under investigation include: FLEX-HD (DEVICE), Strattice (DEVICE).
Who is sponsoring clinical trial NCT01987700?
This trial is sponsored by Musculoskeletal Transplant Foundation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.